• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从卵巢癌腹水中分离单核细胞群体。

Isolation of Mononuclear Cell Populations from Ovarian Carcinoma Ascites.

作者信息

Wefers Christina, Bakdash Ghaith, Martin Meritxell Mereno, Boer Tjitske Duiveman-de, Torensma Ruurd, Massuger Leon F A G, de Vries Jolanda I M

机构信息

Department of Obstetrics & Gynecology, Radboudumc, Nijmegen, The Netherlands.

Department of Tumor Immunology, Radboudumc, Nijmegen, The Netherlands.

出版信息

Bio Protoc. 2017 Apr 5;7(7):e2219. doi: 10.21769/BioProtoc.2219.

DOI:10.21769/BioProtoc.2219
PMID:34541222
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8410376/
Abstract

Ovarian cancer is one of the most fatal tumors in women. Due to a lack of symptoms and adequate screening methods, patients are diagnosed at advanced stages with extensive tumor burden (Jelovac and Armstrong, 2011). Interestingly, ovarian cancer metastasis is generally found within the peritoneal cavity rather than other tissues (Lengyel, 2010; Tan , 2006 ). The reason behind this tissue tropism of the peritoneal cavity remains elusive. A prominent feature of this selectivity is ascites, the accumulation of fluid within the peritoneal cavity, containing, amongst others, immune cells, tumor cells and various soluble factors that can be involved in the progression of ovarian cancer ( Kipps , 2013 ). The protocol described here is used to isolate mononuclear cells from ascites to study the functionality of the immune system within the peritoneal cavity.

摘要

卵巢癌是女性最致命的肿瘤之一。由于缺乏症状和适当的筛查方法,患者在肿瘤负荷广泛的晚期才被诊断出来(杰洛瓦茨和阿姆斯特朗,2011年)。有趣的是,卵巢癌转移通常发生在腹腔内,而非其他组织(伦吉尔,2010年;谭,2006年)。这种腹腔组织嗜性背后的原因仍然不明。这种选择性的一个突出特征是腹水,即腹腔内液体的积聚,其中除其他物质外,还含有免疫细胞、肿瘤细胞和各种可能参与卵巢癌进展的可溶性因子(基普斯,2013年)。此处描述的方案用于从腹水中分离单核细胞,以研究腹腔内免疫系统的功能。

相似文献

1
Isolation of Mononuclear Cell Populations from Ovarian Carcinoma Ascites.从卵巢癌腹水中分离单核细胞群体。
Bio Protoc. 2017 Apr 5;7(7):e2219. doi: 10.21769/BioProtoc.2219.
2
[Relationship between interleukin-10 level in ascites of patients with primary ovarian epithelial carcinoma and immune defect in peritoneal cavity].[原发性卵巢上皮癌患者腹水中白细胞介素-10水平与腹腔免疫缺陷的关系]
Ai Zheng. 2004 May;23(5):573-6.
3
Pathogenesis of malignant ascites formation: initiating events that lead to fluid accumulation.恶性腹水形成的发病机制:导致液体蓄积的起始事件。
Cancer Res. 1993 Jun 1;53(11):2631-43.
4
PEGylated liposome IHL-305 markedly improved the survival of ovarian cancer peritoneal metastasis in mouse.聚乙二醇化脂质体 IHL-305 显著提高了荷卵巢癌腹膜转移模型小鼠的存活率。
BMC Cancer. 2012 Oct 10;12:462. doi: 10.1186/1471-2407-12-462.
5
Presence of interleukin 10 (IL-10) in the ascites of patients with ovarian and other intra-abdominal cancers.卵巢癌及其他腹腔内癌症患者腹水中白细胞介素10(IL-10)的存在情况。
Cytokine. 1992 Sep;4(5):385-90. doi: 10.1016/1043-4666(92)90082-3.
6
Expression of vascular endothelial growth factor and E-cadherin in human ovarian cancer: association with ascites fluid accumulation and peritoneal dissemination in mouse ascites model.血管内皮生长因子和E-钙黏蛋白在人卵巢癌中的表达:与小鼠腹水模型中腹水积聚和腹膜播散的关系
Jpn J Cancer Res. 2002 Jun;93(6):644-51. doi: 10.1111/j.1349-7006.2002.tb01302.x.
7
Chemoresistance in Ovarian Cancer: The Role of Malignant Ascites卵巢癌中的化疗耐药性:恶性腹水的作用
8
Pathogenesis of ascites tumor growth: vascular permeability factor, vascular hyperpermeability, and ascites fluid accumulation.腹水肿瘤生长的发病机制:血管通透性因子、血管通透性增加及腹水积聚。
Cancer Res. 1995 Jan 15;55(2):360-8.
9
[The expression and association of CD14(+) HLA-DR(Low/-) myeloid-derived suppressor cell-like cells and interleukin-1β in ovarian cancer].[CD14(+) HLA-DR(低/阴性) 髓样来源抑制细胞样细胞与白细胞介素-1β在卵巢癌中的表达及相关性]
Zhonghua Yi Xue Za Zhi. 2017 Sep 12;97(34):2663-2669. doi: 10.3760/cma.j.issn.0376-2491.2017.34.005.
10
GPx3 supports ovarian cancer progression by manipulating the extracellular redox environment.GPx3 通过操纵细胞外氧化还原环境来支持卵巢癌的进展。
Redox Biol. 2019 Jul;25:101051. doi: 10.1016/j.redox.2018.11.009. Epub 2018 Nov 17.

引用本文的文献

1
Targeting Indoleamine 2,3-Dioxygenase in Cancer Models Using the Novel Small Molecule Inhibitor NTRC 3883-0.使用新型小分子抑制剂 NTRC 3883-0 靶向癌症模型中的吲哚胺 2,3-双加氧酶。
Front Immunol. 2021 Jan 28;11:609490. doi: 10.3389/fimmu.2020.609490. eCollection 2020.
2
Chemotherapy sensitivity testing on ovarian cancer cells isolated from malignant ascites.对从恶性腹水中分离出的卵巢癌细胞进行化疗敏感性测试。
Oncotarget. 2020 Dec 8;11(49):4570-4581. doi: 10.18632/oncotarget.27827.
3
Survival of Ovarian Cancer Patients Is Independent of the Presence of DC and T Cell Subsets in Ascites.卵巢癌患者的生存与腹水内 DC 和 T 细胞亚群的存在无关。
Front Immunol. 2019 Jan 11;9:3156. doi: 10.3389/fimmu.2018.03156. eCollection 2018.
4
Immune Curbing of Cancer Stem Cells by CTLs Directed to NANOG.通过靶向NANOG的细胞毒性T淋巴细胞对癌症干细胞的免疫抑制
Front Immunol. 2018 Jun 19;9:1412. doi: 10.3389/fimmu.2018.01412. eCollection 2018.

本文引用的文献

1
Expansion of a BDCA1+CD14+ Myeloid Cell Population in Melanoma Patients May Attenuate the Efficacy of Dendritic Cell Vaccines.黑色素瘤患者中 BDCA1+CD14+ 髓样细胞群体的扩增可能会削弱树突状细胞疫苗的疗效。
Cancer Res. 2016 Aug 1;76(15):4332-46. doi: 10.1158/0008-5472.CAN-15-1695. Epub 2016 Jun 20.
2
Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research.应对卵巢癌腹水挑战:治疗和研究的新途径。
Nat Rev Cancer. 2013 Apr;13(4):273-82. doi: 10.1038/nrc3432. Epub 2013 Feb 21.
3
Recent progress in the diagnosis and treatment of ovarian cancer.卵巢癌的诊断与治疗新进展。
CA Cancer J Clin. 2011 May-Jun;61(3):183-203. doi: 10.3322/caac.20113. Epub 2011 Apr 26.
4
Ovarian cancer development and metastasis.卵巢癌的发生和转移。
Am J Pathol. 2010 Sep;177(3):1053-64. doi: 10.2353/ajpath.2010.100105. Epub 2010 Jul 22.
5
Mechanisms of transcoelomic metastasis in ovarian cancer.卵巢癌的经体腔转移机制。
Lancet Oncol. 2006 Nov;7(11):925-34. doi: 10.1016/S1470-2045(06)70939-1.